Thomas W LeBlanc1. 1. Duke University School of Medicine; and Duke Cancer Institute, Duke University Medical Center, Durham, NC thomas.leblanc@duke.edu.
Authors: Anjali V Desai; Virginia M Klimek; Kimberly Chow; Andrew S Epstein; Camila Bernal; Kelly Anderson; Molly Okpako; Robin Rawlins-Duell; Dana Kramer; Danielle Romano; Jessica I Goldberg; Judith E Nelson Journal: J Oncol Pract Date: 2018-12 Impact factor: 3.840
Authors: Kathryn Elizabeth Hudson; Steven Paul Wolf; Gregory P Samsa; Arif H Kamal; Amy Pickar Abernethy; Thomas William LeBlanc Journal: J Palliat Med Date: 2018-02-08 Impact factor: 2.947
Authors: Thomas W LeBlanc; Jonathan D O'Donnell; Megan Crowley-Matoka; Michael W Rabow; Cardinale B Smith; Douglas B White; Greer A Tiver; Robert M Arnold; Yael Schenker Journal: J Oncol Pract Date: 2015-03 Impact factor: 3.840
Authors: Winnie S Wang; Joseph D Ma; Sandahl H Nelson; Carolyn Revta; Gary T Buckholz; Carolyn Mulroney; Eric J Roeland Journal: Support Care Cancer Date: 2017-12-28 Impact factor: 3.603
Authors: Thomas W LeBlanc; Christine S Ritchie; Fred Friedman; Janet Bull; Jean S Kutner; Kimberly S Johnson; Arif H Kamal Journal: J Pain Symptom Manage Date: 2016-11-01 Impact factor: 3.612
Authors: Michael J Hochman; Yinxi Yu; Steven P Wolf; Greg P Samsa; Arif H Kamal; Thomas W LeBlanc Journal: J Pain Symptom Manage Date: 2017-09-05 Impact factor: 3.612
Authors: Dorothy McCaughan; Eve Roman; Alexandra G Smith; Anne C Garry; Miriam J Johnson; Russell D Patmore; Martin R Howard; Debra A Howell Journal: BMC Palliat Care Date: 2018-02-21 Impact factor: 3.234